IP Verse

Csl competitive analysis

Loading summary...

Latest oppositions filed by Csl

Explore patent oppositions filed by Csl against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3116527
Method For Preparing Human Plasma ProteinsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
EP3071219
Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase InhibitorSHIRE VIROPHARMAAug 14, 2019
EP2968434
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018
EP1974014
Oligopeptide-Free Cell Culture MediaBAXALTAJan 18, 2018

Latest patents of Csl opposed by its competitors

Explore Csl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3763384
Aug 28, 2024Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
EP3728287
Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl Glycosides1
EP3794013
Feb 21, 2024Method And System Of Protein Extraction1
EP3715356
Oct 11, 2023Method Of Purifying Polypeptides1
EP3564267
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
EP3226895
Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
EP3383894
May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins1
EP2513135
Apr 22, 2020Method Of Purifying Polypeptides1
EP2538975
Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation1
EP3006462
Apr 10, 2019Method For Purification Of Alpha-1-Antitrypsin1

Latest publications and patents of Csl New

Explore the latest publications and patents granted to Csl, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Csl

EP3763384
Aug 28, 2024Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsGranted And Under Opposition
EP3728287
Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl GlycosidesGranted And Under Opposition
EP3794013
Feb 21, 2024Method And System Of Protein ExtractionGranted And Under Opposition
EP3715356
Oct 11, 2023Method Of Purifying PolypeptidesGranted And Under Opposition
EP3564267
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityGranted And Under Opposition
EP3226895
Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsGranted And Under Opposition
EP3383894
May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent ProteinsGranted And Under Opposition
EP2513135
Apr 22, 2020Method Of Purifying PolypeptidesGranted And Under Opposition
EP2538975
Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin PreparationGranted And Under Opposition
EP3006462
Apr 10, 2019Method For Purification Of Alpha-1-AntitrypsinRevoked

Latest PTAB cases involving Csl

Discover the latest PTAB cases involving Csl, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Csl

IPR2019-00459Dec 21, 2018CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2017-01512May 31, 2017CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Csl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CSL BEHRING394 -
BAXTER927515
BIOVERATIV THERAPEUTICS33 - 2
SHIRE VIROPHARMA INCORPORATED - 3 - 2